| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
| Sales | 590 | 730 | 730 | 880 | 820 |
| Sales Growth | -19.18% | unch | -17.05% | +7.32% | +5.13% |
| Net Income | -2,390 | -1,640 | -2,310 | -600 | -60 |
| Net Income Growth | -45.73% | +29.00% | -285.00% | -900.02% | -200.01% |
Positron Corp (POSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Positron Corporation is engaged in designing, manufacturing, marketing and supporting advanced medical imaging devices utilizing positron emissiontomography technology under the trade name POSICAM systems. POSICAM systems incorporate patented and proprietary technology for the diagnosis and treatment of patients in the areas of oncology, cardiology and neurology.
Fiscal Year End Date: 12/31